# EDGAR Filing Document

**Accession Number:** 0001912966
**File Stem:** 0001213900-26-017528
**Filing Date:** 2026-2
**Character Count:** 27449
**Document Hash:** 6601bcdf420dc16a8d22978c0274cd6d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-017528.hdr.sgml**: 20260217

**ACCESSION NUMBER**: 0001213900-26-017528

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13G

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260217

**DATE AS OF CHANGE**: 20260217

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** REGENTIS BIOMATERIALS LTD.
- **CENTRAL INDEX KEY:** 0001912966
- **STANDARD INDUSTRIAL CLASSIFICATION:** ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** L3
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-95519
- **FILM NUMBER:** 26644047

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 12 HA'ILAN STREET, NORTHERN INDUSTRIAL
- **STREET 2:** ZONE, P.O. BOX 260
- **CITY:** OR AKIVA
- **PROVINCE COUNTRY:** L3
- **BUSINESS PHONE:** 30600

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 12 HA'ILAN STREET, NORTHERN INDUSTRIAL
- **STREET 2:** ZONE, P.O. BOX 260
- **CITY:** OR AKIVA
- **PROVINCE COUNTRY:** L3
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** GELLER EHUD
- **CENTRAL INDEX KEY:** 0001284386

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G

**MAIL ADDRESS:**
- **STREET 1:** 100 PHILIPS PARKWAY
- **CITY:** MONTVALE
- **STATE:** NJ
- **ZIP:** 07645

## Exhibit 99.1

**Exhibit 1**

**<u>JOINT FILING AGREEMENT</u>** 

The undersigned parties hereby agree that this Statement on Schedule 13G filed herewith, and any amendments thereto filed hereafter by any of the undersigned parties, relating to the ordinary shares, no par value per share, of Regentis Biomaterials Ltd., is being (and will be, in the case of amendments hereto) filed jointly with the Securities and Exchange Commission pursuant to Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended, on behalf of each such person.

---

| | |
|:---|:---|
| By: | /s/ Ehud Geller |
| Name: | Ehud Geller |

---

---

| |
|:---|
| MEDICA III INVESTMENTS (INTERNATIONAL) L.P. |
| MEDICA III INVESTMENTS (ISRAEL) L.P. |
| MEDICA III INVESTMENTS (S.F.) L.P. |
| MEDICA III INVESTMENTS (P.F.) L.P. |
| MEDICA III INVESTMENTS (ISRAEL) (B) L.P. |
| POALIM MEDICA INVESTMENTS L.P. |

---

---

| | |
|:---|:---|
| By: Medica III Management L.P., its general partner | By: Medica III Management L.P., its general partner |
| By: | /s/ Ehud Geller |
| Name: | Ehud Geller |
| Title: | General Partner |

---

Dated: February 17, 2026

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13G

### Under the Securities Exchange Act of 1934

**Issuer:** REGENTIS BIOMATERIALS LTD.

**Title of Class of Securities:** Ordinary Shares, no par value

**CUSIP Number:** M8211G108

**Date of Event Which Requires Filing of this Statement:** 12/31/2025

**Check the appropriate box to designate the rule pursuant to which this Schedule is filed:**

- [ ] Rule 13d-1(b)

- [ ] Rule 13d-1(c)

- [x] Rule 13d-1(d)

---

| 1. | Names of Reporting Persons<br>Dr. Ehud Geller | Names of Reporting Persons<br>Dr. Ehud Geller |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>L3 | Citizenship or Place of Organization<br>L3 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>1332867.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>1332867.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>1332867.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>1332867.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>23.2% | Percent of Class Represented by Amount in Row (9)<br>23.2% |
| 12. | Type of Reporting Person (See Instructions)<br>IN | Type of Reporting Person (See Instructions)<br>IN |

**Comment for Type of Reporting Person:** (1) Includes 465,533 options ("Options") exercisable into 465,533 Ordinary shares and (viii) 92,821 warrants ("Warrants") exercisable into 92,821 Ordinary shares that are currently exercisable or will be exercisable within 60 days after December 31, 2025.

(2) This amount of shares and percentage relates to all the Reporting Persons and is based on 5,179,378 Ordinary Shares of the Issuer's issued and outstanding as of February 20, 2026, which number was provided to the Reporting Person by the Issuer, plus the 465,533 Ordinary Shares of the Issuer issuable upon the exercise of the Options and the 92,821 Ordinary Shares of the Issuer issuable upon the exercise of the Warrants.

---

| 1. | Names of Reporting Persons<br>Medica III Investments (International) L.P. | Names of Reporting Persons<br>Medica III Investments (International) L.P. |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>E9 | Citizenship or Place of Organization<br>E9 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>1332867.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>1332867.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>1332867.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>1332867.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>23.2% | Percent of Class Represented by Amount in Row (9)<br>23.2% |
| 12. | Type of Reporting Person (See Instructions)<br>PN | Type of Reporting Person (See Instructions)<br>PN |

**Comment for Type of Reporting Person:** (1) Includes 465,533 options ("Options") exercisable into 465,533 Ordinary shares and (viii) 92,821 warrants ("Warrants") exercisable into 92,821 Ordinary shares that are currently exercisable or will be exercisable within 60 days after December 31, 2025.

(2) This amount of shares and percentage relates to all the Reporting Persons and is based on 5,179,378 Ordinary Shares of the Issuer's issued and outstanding as of February 20, 2026, which number was provided to the Reporting Person by the Issuer, plus the 465,533 Ordinary Shares of the Issuer issuable upon the exercise of the Options and the 92,821 Ordinary Shares of the Issuer issuable upon the exercise of the Warrants.

---

| 1. | Names of Reporting Persons<br>Medica III Investments (Israel) L.P. | Names of Reporting Persons<br>Medica III Investments (Israel) L.P. |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>L3 | Citizenship or Place of Organization<br>L3 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>1332867.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>1332867.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>1332867.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>1332867.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>23.2% | Percent of Class Represented by Amount in Row (9)<br>23.2% |
| 12. | Type of Reporting Person (See Instructions)<br>PN | Type of Reporting Person (See Instructions)<br>PN |

**Comment for Type of Reporting Person:** (1) Includes 465,533 options ("Options") exercisable into 465,533 Ordinary shares and (viii) 92,821 warrants ("Warrants") exercisable into 92,821 Ordinary shares that are currently exercisable or will be exercisable within 60 days after December 31, 2025.

(2) This amount of shares and percentage relates to all the Reporting Persons and is based on 5,179,378 Ordinary Shares of the Issuer's issued and outstanding as of February 20, 2026, which number was provided to the Reporting Person by the Issuer, plus the 465,533 Ordinary Shares of the Issuer issuable upon the exercise of the Options and the 92,821 Ordinary Shares of the Issuer issuable upon the exercise of the Warrants.

---

| 1. | Names of Reporting Persons<br>Medica III Investments (S.F.) L.P. | Names of Reporting Persons<br>Medica III Investments (S.F.) L.P. |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>E9 | Citizenship or Place of Organization<br>E9 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>1332867.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>1332867.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>1332867.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>1332867.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>23.2% | Percent of Class Represented by Amount in Row (9)<br>23.2% |
| 12. | Type of Reporting Person (See Instructions)<br>PN | Type of Reporting Person (See Instructions)<br>PN |

**Comment for Type of Reporting Person:** (1) Includes 465,533 options ("Options") exercisable into 465,533 Ordinary shares and (viii) 92,821 warrants ("Warrants") exercisable into 92,821 Ordinary shares that are currently exercisable or will be exercisable within 60 days after December 31, 2025.

(2) This amount of shares and percentage relates to all the Reporting Persons and is based on 5,179,378 Ordinary Shares of the Issuer's issued and outstanding as of February 20, 2026, which number was provided to the Reporting Person by the Issuer, plus the 465,533 Ordinary Shares of the Issuer issuable upon the exercise of the Options and the 92,821 Ordinary Shares of the Issuer issuable upon the exercise of the Warrants.

---

| 1. | Names of Reporting Persons<br>Medica III Investments (P.F.) L.P. | Names of Reporting Persons<br>Medica III Investments (P.F.) L.P. |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>L3 | Citizenship or Place of Organization<br>L3 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>1332867.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>1332867.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>1332867.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>1332867.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>23.2% | Percent of Class Represented by Amount in Row (9)<br>23.2% |
| 12. | Type of Reporting Person (See Instructions)<br>PN | Type of Reporting Person (See Instructions)<br>PN |

**Comment for Type of Reporting Person:** (1) Includes 465,533 options ("Options") exercisable into 465,533 Ordinary shares and (viii) 92,821 warrants ("Warrants") exercisable into 92,821 Ordinary shares that are currently exercisable or will be exercisable within 60 days after December 31, 2025.

(2) This amount of shares and percentage relates to all the Reporting Persons and is based on 5,179,378 Ordinary Shares of the Issuer's issued and outstanding as of February 20, 2026, which number was provided to the Reporting Person by the Issuer, plus the 465,533 Ordinary Shares of the Issuer issuable upon the exercise of the Options and the 92,821 Ordinary Shares of the Issuer issuable upon the exercise of the Warrants.

---

| 1. | Names of Reporting Persons<br>Medica III Investments Israel (B) L.P. | Names of Reporting Persons<br>Medica III Investments Israel (B) L.P. |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>L3 | Citizenship or Place of Organization<br>L3 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>1332867.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>1332867.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>1332867.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>1332867.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>23.2% | Percent of Class Represented by Amount in Row (9)<br>23.2% |
| 12. | Type of Reporting Person (See Instructions)<br>PN | Type of Reporting Person (See Instructions)<br>PN |

**Comment for Type of Reporting Person:** (1) Includes 465,533 options ("Options") exercisable into 465,533 Ordinary shares and (viii) 92,821 warrants ("Warrants") exercisable into 92,821 Ordinary shares that are currently exercisable or will be exercisable within 60 days after December 31, 2025.

(2) This amount of shares and percentage relates to all the Reporting Persons and is based on 5,179,378 Ordinary Shares of the Issuer's issued and outstanding as of February 20, 2026, which number was provided to the Reporting Person by the Issuer, plus the 465,533 Ordinary Shares of the Issuer issuable upon the exercise of the Options and the 92,821 Ordinary Shares of the Issuer issuable upon the exercise of the Warrants.

---

| 1. | Names of Reporting Persons<br>Poalim Medica III Investments L.P. | Names of Reporting Persons<br>Poalim Medica III Investments L.P. |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>L3 | Citizenship or Place of Organization<br>L3 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>1332867.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>1332867.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>1332867.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>1332867.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>23.2% | Percent of Class Represented by Amount in Row (9)<br>23.2% |
| 12. | Type of Reporting Person (See Instructions)<br>PN | Type of Reporting Person (See Instructions)<br>PN |

**Comment for Type of Reporting Person:** (1) Includes 465,533 options ("Options") exercisable into 465,533 Ordinary shares and (viii) 92,821 warrants ("Warrants") exercisable into 92,821 Ordinary shares that are currently exercisable or will be exercisable within 60 days after December 31, 2025.

(2) This amount of shares and percentage relates to all the Reporting Persons and is based on 5,179,378 Ordinary Shares of the Issuer's issued and outstanding as of February 20, 2026, which number was provided to the Reporting Person by the Issuer, plus the 465,533 Ordinary Shares of the Issuer issuable upon the exercise of the Options and the 92,821 Ordinary Shares of the Issuer issuable upon the exercise of the Warrants.

---

**Item 1(a). Name of Issuer:**
REGENTIS BIOMATERIALS LTD.

**Item 1(b). Address of Issuer's Principal Executive Offices:**
60 Medinat Hayehudim, 4676652, Israel.

**Item 2(a). Name of Person Filing:**
The following entities and individual, listed below, who are filing this Statement of Beneficial Ownership on Schedule 13G (this "Statement"), are referred to herein collectively as the "Reporting Persons":

1. Ehud Geller, an Israeli Citizen;
2. Medica III Investments (International) L.P. a Cayman Islands limited Partnership;
3. Medica III Investments (Israel) L.P. an Israeli limited partnership;
4. Medica III Investments (S.F.) L.P. a Cayman Islands limited partnership;
5. Medica III Investments (P.F.) L.P. an Israeli limited partnership;
6. Medica III Investments (Israel) (B) L.P. an Israeli limited partnership; and
7. Poalim Medica III Investments L.P. an Israeli limited partnership.

**Item 2(b). Address of Principal Business Office:**
The principal business address of the Reporting Persons is 60C Medinat Hayehudim, Herzliya, 4676670, Israel.

**Item 2(c). Citizenship:**
Each of the entities or persons identified in Item 2(a) above is a corporation, limited partnership or individual organized under the laws of the jurisdiction, or is a citizen of the jurisdiction, as applicable, set forth opposite such entity's or person's name.

**Item 2(d). Title of Class of Securities:**
Ordinary Shares, no par value

**Item 2(e). CUSIP Number:**
M8211G108

**Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:**

(a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

(d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

(e) [ ] An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f) [ ] An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g) [ ] A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j) [ ] A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), if filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:

(k) [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

**Item 4. Ownership:**

**(a) Amount beneficially owned:**

Dr. Ehud Geller                                               1,332,867.00 Ordinary Shares
Medica III Investments (International) L.P.     1,332,867.00 Ordinary Shares
Medica III Investments (Israel) L.P.                1,332,867.00 Ordinary Shares
Medica III Investments (S.F.) L.P.                   1,332,867.00 Ordinary Shares
Medica III Investments (P.F.) L.P.                   1,332,867.00 Ordinary Shares
Medica III Investments Israel (B) L.P.            1,332,867.00 Ordinary Shares
Poalim Medica III Investments L.P.               1,332,867.00 Ordinary Shares

**(b) Percent of class:**

Dr. Ehud Geller                                               23.2%*
Medica III Investments (International) L.P.     23.2%*
Medica III Investments (Israel) L.P.                23.2%*
Medica III Investments (S.F.) L.P.                   23.2%*
Medica III Investments (P.F.) L.P.                  23.2%*
Medica III Investments Israel (B) L.P.           23.2%*
Poalim Medica III Investments L.P.              23.2%*
* This amount of shares and percentage relates to all the Reporting Persons and is based on 5,179,378 Ordinary Shares of the Issuer's issued and outstanding as of February 20, 2026, which number was provided to the Reporting Person by the Issuer, plus the 465,533 Ordinary Shares of the Issuer issuable upon the exercise of the Options and the 92,821 Ordinary Shares of the Issuer issuable upon the exercise of the Warrants.

**(c) Number of shares as to which the person has:**

**(i) Sole power to vote or to direct the vote:**

Dr. Ehud Geller                                               0
Medica III Investments (International) L.P.     0
Medica III Investments (Israel) L.P.                 0
Medica III Investments (S.F.) L.P.                   0
Medica III Investments (P.F.) L.P.                   0
Medica III Investments Israel (B) L.P.             0
Poalim Medica III Investments L.P.                0

**(ii) Shared power to vote or to direct the vote:**

Dr. Ehud Geller                                              1,332,867
Medica III Investments (International) L.P.     1,332,867
Medica III Investments (Israel) L.P.                1,332,867
Medica III Investments (S.F.) L.P.                   1,332,867
Medica III Investments (P.F.) L.P.                   1,332,867
Medica III Investments Israel (B) L.P.             1,332,867
Poalim Medica III Investments L.P.                1,332,867

**(iii) Sole power to dispose or to direct the disposition of:**

Dr. Ehud Geller                                               0
Medica III Investments (International) L.P.     0
Medica III Investments (Israel) L.P.                 0
Medica III Investments (S.F.) L.P.                   0
Medica III Investments (P.F.) L.P.                   0
Medica III Investments Israel (B) L.P.             0
Poalim Medica III Investments L.P.                0

**(iv) Shared power to dispose or to direct the disposition of:**

Dr. Ehud Geller                                              1,332,867
Medica III Investments (International) L.P.     1,332,867
Medica III Investments (Israel) L.P.                1,332,867
Medica III Investments (S.F.) L.P.                   1,332,867
Medica III Investments (P.F.) L.P.                   1,332,867
Medica III Investments Israel (B) L.P.             1,332,867
Poalim Medica III Investments L.P.                1,332,867

**Item 5. Ownership of Five Percent or Less of a Class.**

[ ] If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following.

**Item 6. Ownership of More than 5 Percent on Behalf of Another Person.**

Not Applicable

**Item 7. Identification and Classification of the Subsidiary**

Not Applicable

**Item 8. Identification and Classification of Members of the Group**

Not Applicable

**Item 9. Notice of Dissolution of Group**

Not Applicable

**Item 10. Certification:**

—

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Dr. Ehud Geller**

**Date:** 02/17/2026

**By:** /s/ Ehud Geller

**Name & Title:** Ehud Geller

**Medica III Investments (International) L.P.**

**Date:** 02/17/2026

**By:** /s/ Ehud Geller

**Name & Title:** Ehud Geller/General Partner

**Medica III Investments (Israel) L.P.**

**Date:** 02/17/2026

**By:** /s/ Ehud Geller

**Name & Title:** Ehud Geller/General Partner

**Medica III Investments (S.F.) L.P.**

**Date:** 02/17/2026

**By:** /s/ Ehud Geller

**Name & Title:** Ehud Geller/General Partner

**Medica III Investments (P.F.) L.P.**

**Date:** 02/17/2026

**By:** /s/ Ehud Geller

**Name & Title:** Ehud Geller/General Partner

**Medica III Investments Israel (B) L.P.**

**Date:** 02/17/2026

**By:** /s/ Ehud Geller

**Name & Title:** Ehud Geller/General Partner

**Poalim Medica III Investments L.P.**

**Date:** 02/17/2026

**By:** /s/ Ehud Geller

**Name & Title:** Ehud Geller/General Partner